Patents Represented by Attorney Carol A. Fang
  • Patent number: 8124740
    Abstract: The present invention provides new anti-?5?1 antibodies, compositions and kits comprising the antibodies, and methods of making and using the antibodies.
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: February 28, 2012
    Assignee: Genentech, Inc.
    Inventors: Wei-Ching Liang, Gregory D. Plowman, Yan Wu, Weilan Ye
  • Patent number: 8008004
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumors of glial origin in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: January 19, 2007
    Date of Patent: August 30, 2011
    Assignee: Genentech Inc.
    Inventor: Heidi S. Phillips
  • Patent number: 7834154
    Abstract: The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: November 16, 2010
    Assignee: Genentech, Inc.
    Inventors: Alexander W. Koch, Scott Stawicki, Yan Wu, Richard Carano, Franklin V. Peale, Jr., Ryan J. Watts
  • Patent number: 7371377
    Abstract: The present invention involves the identification and preparation of vascular endothelial growth factor-E (VEGF-E). VEGF-E is a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1. VEGF-E has homology to VEGF including conservation of the amino acids required for activity of VEGF. VEGF-E can be useful in wound repair, as well as in the generation and regeneration of tissue.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: May 13, 2008
    Assignee: Genentech, Inc.
    Inventors: Napoleone Ferrara, Sophia S. Kuo